Abstract
The evolution of ever more sophisticated oncologic imaging and technologies providing far more precise radiation therapy have combined to increase the utilization of sophisticated radiation therapy in childhood cancer. For a majority of children with common central nervous system, soft tissue, bone, and dysontogenic neoplasms, local irradiation is fundamental to successful multi-disciplinary management. Along with more precise target volume definition and radiation delivery, new technologies provide added certainty of patient positioning (electronic portal imaging, cone beam CT) and conformality of dose delivery (3-D conformal irradiation, intensity modulated radiation therapy, proton beam therapy). Each of the major areas of technology development are able to better confine the high-dose region to the intended target, but they are also associated with the potential for larger volumes of uninvolved tissues being exposed to low radiation doses. The latter issue plays a role in documented levels of secondary carcinogenesis, sometimes with greater anticipated incidence than that seen in conventional radiation therapy. Parameters related to carcinogenesis, such as dose–volume relationships and neutron contamination that accompanies high-energy photon irradiation and proton therapy, can be identified, sometimes modulated, and accepted as part of the clinical decision process in fine tuning radiation therapy in this more vulnerable age group.
Similar content being viewed by others
References
Suit H, Goldberg S, Niemierko A et al (2007) Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat Res 167:12–42
Smilenov LB, Lieberman HB, Mitchell SA et al (2005) Combined haploinsufficiency for ATM and RAD9 as a factor in cell transformation, apoptosis, and DNA lesion repair dynamics. Cancer Res 65:933–938
Brenner D, Elliston C, Hall E et al (2001) Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR 176:289–296
Hall EJ (2006) Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65:1–7
International Commission on Radiological Protection. Recommendations. Annals of the ICRP Publication 60. Pergamon, Oxford, England
Travis LB, Rabkin CS, Brown LM et al (2006) Cancer survivorship—genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst 98:15–25
Brenner DJ, Hall EJ (2008) Secondary neutrons in clinical proton radiotherapy: a charged issue. Radiother Oncol 86:165–170
Hall EJ, Wuu CS (2003) Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56:83–88
Verellen D, De RM, Storme G (2008) A (short) history of image-guided radiotherapy. Radiother Oncol 86:4–13
Galvin JM, Ezzell G, Eisbrauch A et al (2004) Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys 58:1616–1634
Nutting C, Dearnaley DP, Webb S (2000) Intensity modulated radiation therapy: a clinical review. Br J Radiol 73:459–469
Guerrero Urbano MT, Nutting CM (2004) Clinical use of intensity-modulated radiotherapy: part I. Br J Radiol 77:88–96
Huang E, Teh BS, Strother DR et al (2002) Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. Int J Radiat Oncol Biol Phys 52:599–605
Klein EE, Maserang B, Wood R et al (2006) Peripheral doses from pediatric IMRT. Med Phys 33:2525–2531
Guerrero Urbano MT, Nutting CM (2004) Clinical use of intensity-modulated radiotherapy: part II. Br J Radiol 77:177–182
Followill D, Geis P, Boyer A (1997) Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy. Int J Radiat Oncol Biol Phys 38:667–672
Xu XG, Bednarz B, Paganetti H (2008) A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction. Phys Med Biol 53:R193–R241
Bhatia S, Yasui Y, Robison LL et al (2003) High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol 21:4386–4394
Bhatia S, Robison LL, Oberlin O et al (1996) Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334:745–751
Kudchadker RJ, Chang EL, Bryan F et al (2004) An evaluation of radiation exposure from portal films taken during definitive course of pediatric radiotherapy. Int J Radiat Oncol Biol Phys 59:1229–1235
Olch AJ, Geurts M, Thomadsen B et al (2007) Portal imaging practice patterns of children's oncology group institutions: dosimetric assessment and recommendations for minimizing unnecessary exposure. Int J Radiat Oncol Biol Phys 67:594–600
Peng LC, Yang CC, Sim S et al (2007) Dose comparison of megavoltage cone-beam and orthogonal-pair portal images. J Appl Clin Med Phys 8:10–20
Morin O, Gillis A, Descovich M et al (2007) Patient dose considerations for routine megavoltage cone-beam CT imaging. Med Phys 34:1819–1827
Beltran C, Bani-Hashemi A, Faddegon B et al (2006) Low dose MV CBCT for daily pediatric localization. Int J Radiat Oncol Biol Phys 72(1 Supplement):S678 2008
Jones B (2006) The case for particle therapy. Br J Radiol 79:24–31
Levin WP, Kooy H, Loeffler JS et al (2005) Proton beam therapy. Br J Cancer 93:849–854
Merchant TE, Hua CH, Shukla H et al (2008) Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer 51:110–117
Brada M, Pijls-Johannesma M, De RD (2007) Proton therapy in clinical practice: current clinical evidence. J Clin Oncol 25:965–970
Wilson VC, McDonough J, Tochner Z (2005) Proton beam irradiation in pediatric oncology: an overview. J Pediatr Hematol Oncol 27:444–448
Lee CT, Bilton SD, Famiglietti RM et al (2005) Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys 63:362–372
Weber DC, Rutz HP, Bolsi A et al (2007) Spot scanning proton therapy in the curative treatment of adult patients with sarcoma: the Paul Scherrer Institute experience. Int J Radiat Oncol Biol Phys 69:865–871
Yock TI, MacDonald SM, Safai S et al (2008) Proton radiotherapy for ependymoma: initial clinical outcomes and dose comparisons for intensity modulated radiation with photons, proton radiation, and intensity modulated proton therapy. Int J Radiat Oncol Biol Phys 72(1 Supplement):S575–S576
Acknowledgement
Supported in part by the American Lebanese Syrian Associated Charities (ALSAC).
Author information
Authors and Affiliations
Corresponding author
Additional information
Authors have no relevant financial relationships or potential conflicts of interest related to the material to be presented
Rights and permissions
About this article
Cite this article
Kun, L.E., Beltran, C. Radiation therapy for children: evolving technologies in the era of ALARA. Pediatr Radiol 39 (Suppl 1), 65–70 (2009). https://doi.org/10.1007/s00247-008-1098-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-008-1098-0